Forms and Specifications That Matter for Supplement Manufacturers
Standardised dry extract is the primary functional form for nutraceutical applications. Unlike essential oil or crude dried flower, a 4:1 or 5:1 hydroethanolic dry extract concentrates the pharmacologically relevant constituents and allows consistent dosing across production batches.
Key Marker Compounds and Assay Method
The two accepted chemical markers for Lavandula angustifolia extracts are linalool and linalyl acetate, the principal monoterpene constituents referenced in the European Pharmacopoeia (Ph. Eur.) monograph for Lavender flower. Quantification is performed by HPLC-UV or GC-FID depending on whether the extract or the corresponding essential oil fraction is being characterised — HPLC is the standard method for dry extract assay in solid-dosage supplement manufacturing.
Typical extract specifications requested by supplement buyers:
- Extract ratio: 4:1 to 10:1 (hydroethanolic, aqueous, or CO₂ supercritical)
- Linalool content: declared on COA, typically ≥ 20–35% in concentrated extracts (actual figure depends on ratio and solvent system; buyers should request batch-specific HPLC data)
- Loss on drying (LOD): ≤ 5% (consistent with solid capsule filling requirements)
- Particle size (D90): ≤ 250 µm for standard capsule filling; ≤ 100 µm (micronised) for direct-compression tablet grades
- Heavy metals: per Ph. Eur. 2.4.27 limits (Pb ≤ 5 ppm, Cd ≤ 1 ppm, Hg ≤ 0.1 ppm, As ≤ 3 ppm)
- Pesticide residues: compliant with EU MRL Regulation (EC) No 396/2005
- Microbiology: Total aerobic count ≤ 10⁵ CFU/g; absence of Salmonella spp. and E. coli per Ph. Eur. 5.1.4 criteria for herbal extracts
- Aflatoxin: compliant with Commission Regulation (EC) No 1881/2006 limits for botanical ingredients
Particle Size Considerations for Capsule and Tablet Production
Particle size is a practical production parameter that many ingredient catalogues omit. For hard-shell capsule filling (both gelatine and HPMC), a D90 of 150–250 µm provides acceptable flowability without caking. For direct-compression tablets, a micronised D90 ≤ 100 µm is required to ensure uniform blending with excipients. TANDOR coordinates with processing partners to specify particle size at the point of milling and confirms this parameter in the COA. Buyers integrating lavender extract into soft-gel formulations typically request the CO₂ supercritical extract (a viscous oleoresin), which is a distinct product stream.
---
EFSA Health Claim Status
There is currently no authorised Article 13.1 or Article 14 health claim for Lavandula angustifolia under EU Regulation (EC) No 1924/2006 following EFSA evaluation. Supplement brands marketing in the EU must therefore rely on traditional herbal medicinal product (THMP) status under Directive 2004/24/EC (for finished products), general well-being framing, or structure/function language that does not constitute a disease claim. Brands intending to make claim-substantiated products should verify the current EFSA claims register before product development. TANDOR provides raw material supply only and does not provide regulatory affairs advice, but can supply the botanical identity documentation and extract specifications needed to support a THMP dossier.
---
EU Certifications Available
EU Organic (Regulation 2018/848)
EU-Organic certified material is available from Bulgarian and French origins, both of which have established certified cultivation areas for Lavandula angustifolia. Certification is issued by accredited EU control bodies and documented with a valid organic certificate per Article 35 of Regulation (EU) 2018/848. The certificate covers the cultivation site and, where applicable, the extraction facility. TANDOR verifies chain-of-custody documentation before supply.
Additional Certifications Relevant to Supplement Buyers
- GMP (Good Manufacturing Practice): Extraction partners hold EU GMP or equivalent ISO 22000 certification; documentation available on request
- Kosher / Halal: Available from select processing partners; declared at order stage
- FSSC 22000 / BRC: Available for certain origins; confirmed per batch
---
Origin, Processing, and MOQ Realities
Primary Origins
| Origin | Notes |
|---|---|
| Bulgaria | Largest EU producing country; Kazanlak and Stara Zagora regions; both conventional and EU-Organic |
| France | Haute-Provence; premium AOC-adjacent material; EU-Organic available; typically higher unit cost |
| Romania | Emerging cultivation base; TANDOR's home market; direct producer relationships; conventional |
Multi-origin access matters because crop quality and yield fluctuate seasonally. A single-origin dependency creates supply risk; TANDOR's role is to qualify alternative origin material that meets the same COA specifications, giving buyers continuity.
Processing Notes
Dry extract production uses hydroethanolic or aqueous extraction followed by spray drying or vacuum-belt drying. Solvent residues are tested per Ph. Eur. 5.4 (Class 2 and Class 3 solvents) and declared on the COA. CO₂ supercritical extracts are produced without organic solvent and are preferred where a clean-label declaration is a commercial requirement.
Minimum Order Quantities
MOQ for standardised dry extract is typically 5–25 kg depending on origin and extract ratio. Crude dried flower and milled herb grades carry lower MOQs. Sample quantities (100–500 g) are available prior to commercial orders to support formulation development and internal QC testing.
---
Why Source Lavender Extract Through TANDOR?
TANDOR is a Romania-based EU botanical sourcing intermediary, positioned at the intersection of Eastern European and Western European production regions. The practical advantages for supplement brands:
- Batch-level Certificate of Analysis covering identity (botanical microscopy or HPTLC), HPLC assay for linalool/linalyl acetate, particle size, LOD, heavy metals, pesticide residues, and microbiology — not a generic product-level COA
- Multi-origin qualification so that if one supply chain is disrupted by a poor harvest or regulatory issue, an alternative-origin COA-equivalent material can be offered
- EU-Organic chain-of-custody documentation maintained and provided as part of standard supply
- Regulatory documentation package (spec sheet, COA, safety data sheet, supplier declarations) formatted to support EU Food Business Operator and THMP dossier requirements
- Direct communication with extraction facilities — not a catalogue reseller — meaning custom extract ratios, particle sizes, and carrier combinations can be scoped at the inquiry stage
Frequently asked questions
What assay method is used to verify linalool content in lavender dry extract for supplement use?
HPLC is the standard assay method for quantifying linalool and linalyl acetate in lavender dry extracts intended for solid-dosage supplement applications. GC-FID is the reference method for essential oil characterisation per the European Pharmacopoeia monograph, but for dry extracts in capsule and tablet manufacturing, HPLC-UV provides the batch-to-batch quantitative data required by supplement QC teams. TANDOR requests and supplies HPLC-based COA data as standard.
Is EU-Organic certified lavender extract available, and which regulation covers it?
Yes. EU-Organic certified lavender extract is available from Bulgarian and French origins. Certification is governed by EU Regulation 2018/848 on organic production and labelling, which replaced the previous Regulation (EC) No 834/2007. The organic certificate covers the cultivation site and, where applicable, the processing facility. TANDOR provides chain-of-custody documentation confirming organic status for each batch supplied.
What particle size should a supplement manufacturer specify for lavender extract going into HPMC capsules?
For hard-shell HPMC capsule filling, a D90 of 150–250 µm is the practical working range, providing adequate flowability and preventing bridging in filling equipment. If the extract is being blended into a direct-compression tablet formula, a micronised grade with D90 ≤ 100 µm is required to ensure blend uniformity. TANDOR specifies and confirms particle size as a named parameter on the COA — buyers should state their target D90 at the inquiry stage so the milling specification can be aligned before production.
Are there authorised EU health claims for Lavandula angustifolia that supplement brands can use on product labels?
No authorised health claims for Lavandula angustifolia currently appear on the EU Register of authorised nutrition and health claims under Regulation (EC) No 1924/2006 following EFSA assessment. Supplement brands marketing in the EU should either position products under the traditional herbal medicinal product (THMP) framework via Directive 2004/24/EC — which requires a simplified registration and supports traditional use claims — or use general well-being language that does not constitute a disease claim. Regulatory strategy is outside TANDOR's scope, but TANDOR supplies the botanical identity and extract characterisation documentation that supports a THMP registration file.
Need a quote or a sample?
EU-Organic, Certificate of Analysis per batch, multi-origin.
Request a quoteTANDOR Intelligence — briefing mensuel gratuit
Sourcing UE bio des botaniques — mouvements de prix, risques d'approvisionnement, fourchettes spec vérifiées de manière adversariale. Ce que Mintec / Tridge / Expana ferment derrière des abonnements à $5K-25K.
- Fourchettes de prix H2 2026 par origine (7 pillars)
- Mises à jour fenêtre de récolte + glissements de chaîne d'approvisionnement
- Changements réglementaires UE + monographies EMA/Ph. Eur.